- Global Pharma News & Resources

Growing prevalence of sleep disorders will boost the Actigraphy Sensors and Polysomnography (PSG) Devices Market, forecast to touch US$ 1.8 Billion by 2026 at a CAGR of 5.8%

Noida, Uttar Pradesh, India, February 23 2021 (Wiredrelease) Report Ocean Pvt Ltd –:The increasing prevalence of insomnia, growing awareness regarding various treatment options available for sleep-deprived patients, and the wide availability of the concerned devices are the critical drivers for the market growth. The geriatric population is most vulnerable to insomnia and is currently the highest in developed economies which is likely to complement diagnostic devices’ demand. Driven by these promising developments, the Global Actigraphy Sensors and PSG Devices Market is estimated to see healthy growth, pegged at a CAGR of ~5.8% during the forecast period 2020-2026.

Click Here To Access Free Sample Report @

Growing prevalence of sleep disorders are raising demand for actigraphy sensors and PSG devices

The modern lifestyle has altered sleeping patterns, leading to an increase in various sleep disorders. Right from minor sleep disturbances to significant problems, such as insomnia, chronic sleep disorders have adverse impacts on consumers’ quality of life. As actigraphy sensors and PSG devices make it simpler for users to monitor their sleep duration with more convenience and accuracy, diagnosing sleep diseases reliably makes treatments more effective.

Thereby, consumers seek diagnostic services for the proper treatments of sleep disorders, creating a high demand for actigraphy sensors and PSG devices in the healthcare sector. Furthermore, ongoing research in sleep disorder management to discover more efficient medicine and treatments for life-threatening sleep disorders provides a boost to the applications of actigraphy sensors and PSG devices.

Sector Overview

Actigraphy sensors are medical devices used in non-invasive medical treatments that monitor activity cycles in the human body. Actigraphy sensors transmit signals and analyze body movements as well as sleep-related activities in real-time.

Polysomnography (PSG) is the study of sleep, and PSG devices are used as diagnostic tools in sleep medicine. Actigraphy sensors and PSG devices are medical devices primarily used to diagnose various sleep disorders such as idiopathic hypersomnia and sleep apnea.

Manufacturers in the actigraphy sensor and PSG devices market experiment with various technologies, such as radar technology, to discover the most accurate and reliable method for sleep analysis. Leading market players shifting their focus on increasing the use of technologies to launch innovative and more efficient actigraphy sensor and PSG devices to scale up on the competitive landscape in the diagnostics industry.

Segmentation Overview of the Global Actigraphy Sensors and PSG Devices Market

The actigraphy sensors and PSG devices market has been segmented into Product, Technology, and Distribution Channel. These major market segments are further categorized into various sub-segments to study the market in detail.

By Product Outlook

Actigraphy Devices (Wrist and Handband Devices, Wearable Devices)
Polysomnography Devices (Fixed, Portable)

By Technology Outlook (Wireless, USB, GPS, Others)

By Distribution Channel Outlook (Retail Stores, Online Retail Stores, Pharmacies, Hospitals, Diagnostic Laboratories, Homecare Settings)

Key Players Insights

Garmin Ltd., Fitbit, Inc., Koninklijke Philips N.V., Aetna Inc., MEDISANA GmbH, BMC Medical Co., Ltd., Activinsights Ltd., SOMNOmedics GmbH, ResMed Inc., Recorders & Medicare Systems Pvt Ltd, Compumedics, Ltd., Cleveland Medical Devices Inc., Natus Medical, Inc., Cidelec, iHealth Labs Inc., ActiGraph, LLC, Medicom MTD, and Nox Medical, among others, are some significant players included in the research study of the global actigraphy sensors and PSG devices market.

For Purchase Enquiry: @

This content has been published by Report Ocean Pvt Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 23-Feb-2021